- Home
- CORT vs LLYVK Comparison
CORT vs LLYVK Comparison
Compare CORT & LLYVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- LLYVK
- Stock Information
- Founded
- CORT 1998
- LLYVK 1991
- Country
- CORT United States
- LLYVK United States
- Employees
- CORT N/A
- LLYVK N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- LLYVK Broadcasting
- Sector
- CORT Health Care
- LLYVK Industrials
- Exchange
- CORT Nasdaq
- LLYVK Nasdaq
- Market Cap
- CORT 8.8B
- LLYVK 8.4B
- IPO Year
- CORT N/A
- LLYVK N/A
- Fundamental
- Price
- CORT $76.81
- LLYVK $90.25
- Analyst Decision
- CORT Strong Buy
- LLYVK
- Analyst Count
- CORT 4
- LLYVK 0
- Target Price
- CORT $139.00
- LLYVK N/A
- AVG Volume (30 Days)
- CORT 1.0M
- LLYVK 273.8K
- Earning Date
- CORT 10-29-2025
- LLYVK 01-01-0001
- Dividend Yield
- CORT N/A
- LLYVK N/A
- EPS Growth
- CORT N/A
- LLYVK N/A
- EPS
- CORT 1.11
- LLYVK N/A
- Revenue
- CORT $716,080,000.00
- LLYVK N/A
- Revenue This Year
- CORT $30.77
- LLYVK N/A
- Revenue Next Year
- CORT $37.75
- LLYVK $11.45
- P/E Ratio
- CORT $70.90
- LLYVK N/A
- Revenue Growth
- CORT 25.71
- LLYVK N/A
- 52 Week Low
- CORT $42.01
- LLYVK $54.20
- 52 Week High
- CORT $117.33
- LLYVK $102.62
- Technical
- Relative Strength Index (RSI)
- CORT 45.45
- LLYVK 43.48
- Support Level
- CORT $69.43
- LLYVK $87.82
- Resistance Level
- CORT $91.00
- LLYVK $89.98
- Average True Range (ATR)
- CORT 4.07
- LLYVK 2.06
- MACD
- CORT -1.83
- LLYVK -0.67
- Stochastic Oscillator
- CORT 34.21
- LLYVK 33.75
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About LLYVK Liberty Media Corporation
Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's planning for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.